Literature DB >> 18785961

Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.

H J Huang1, R D Yusen, B F Meyers, M J Walter, T Mohanakumar, G A Patterson, E P Trulock, R R Hachem.   

Abstract

Primary graft dysfunction (PGD) is a common early complication after lung transplantation. We conducted a retrospective cohort study of 334 recipients to evaluate the impact of PGD graded at 24, 48 and 72 h on the risk of bronchiolitis obliterans syndrome (BOS) development (stage 1) and progression (stages 2 and 3). We constructed multivariable Cox proportional hazards models to determine the risk of BOS attributable to PGD in the context of other potential risk factors including acute rejection, lymphocytic bronchitis and respiratory viral infections. All grades of PGD at all time points were significant risk factors for BOS development and progression independent of acute rejection, lymphocytic bronchitis and respiratory viral infections. Specifically, PGD grade 1 at T24 was associated with a relative risk of BOS stage 1 of 1.93, grade 2 with a relative risk of 2.29 and grade 3 with a relative risk of 3.31. Furthermore, this direct relationship between the severity of PGD and the risk of BOS persisted at all time points. We conclude that all grades of PGD at all time points are independent risk factors for BOS development and progression. Future strategies that might attenuate the severity of PGD may mitigate the risk of BOS.

Entities:  

Mesh:

Year:  2008        PMID: 18785961      PMCID: PMC2678949          DOI: 10.1111/j.1600-6143.2008.02389.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  32 in total

Review 1.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Authors:  Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem
Journal:  J Heart Lung Transplant       Date:  2002-03       Impact factor: 10.247

2.  Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome.

Authors:  Andrés Jaramillo; Craig R Smith; Takahiro Maruyama; Leiying Zhang; G Alexander Patterson; T Mohanakumar
Journal:  Hum Immunol       Date:  2003-05       Impact factor: 2.850

3.  Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis.

Authors:  J A Madri; H Furthmayr
Journal:  Hum Pathol       Date:  1980-07       Impact factor: 3.466

Review 4.  Ischemia-reperfusion-induced lung injury.

Authors:  Marc de Perrot; Mingyao Liu; Thomas K Waddell; Shaf Keshavjee
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

5.  Association of humoral immunity and bronchiolitis obliterans syndrome.

Authors:  Cynthia M Magro; Patrick Ross; Moira Kelsey; W James Waldman; Amy Pope-Harman
Journal:  Am J Transplant       Date:  2003-09       Impact factor: 8.086

6.  De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.

Authors:  Trudie A Goers; Sabarinathan Ramachandran; Aviva Aloush; Elbert Trulock; G Alexander Patterson; Thalachallour Mohanakumar
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.

Authors:  Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Kenneth B Schechtman; G Alexander Patterson; Daniel P Schuster; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2004-05-06       Impact factor: 21.405

8.  Lymphocytic bronchitis/bronchiolitis in lung allograft recipients.

Authors:  S A Yousem
Journal:  Am J Surg Pathol       Date:  1993-05       Impact factor: 6.394

9.  Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

Authors:  Scott M Palmer; R Duane Davis; Denis Hadjiliadis; Marshall I Hertz; David N Howell; Fran E Ward; Kay Savik; Nancy L Reinsmoen
Journal:  Transplantation       Date:  2002-09-27       Impact factor: 4.939

10.  A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

Authors:  J D Cooper; M Billingham; T Egan; M I Hertz; T Higenbottam; J Lynch; J Mauer; I Paradis; G A Patterson; C Smith
Journal:  J Heart Lung Transplant       Date:  1993 Sep-Oct       Impact factor: 10.247

View more
  39 in total

1.  The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.

Authors:  A DerHovanessian; S S Weigt; V Palchevskiy; M Y Shino; D M Sayah; A L Gregson; P W Noble; S M Palmer; M C Fishbein; B M Kubak; A Ardehali; D J Ross; R Saggar; J P Lynch; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2015-10-13       Impact factor: 8.086

2.  Systemic sclerosis and bilateral lung transplantation: a single centre experience.

Authors:  R Saggar; D Khanna; D E Furst; J A Belperio; G S Park; S S Weigt; B Kubak; A Ardehali; A Derhovanessian; P J Clements; S Shapiro; C Hunter; A Gregson; M C Fishbein; J P Lynch Iii; D J Ross; R Saggar
Journal:  Eur Respir J       Date:  2010-03-29       Impact factor: 16.671

3.  Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.

Authors:  J M Diamond; S M Kawut; D J Lederer; V N Ahya; B Kohl; J Sonett; S M Palmer; M Crespo; K Wille; V N Lama; P D Shah; J Orens; S Bhorade; A Weinacker; E Demissie; S Bellamy; J D Christie; L B Ware
Journal:  Am J Transplant       Date:  2011-02-07       Impact factor: 8.086

4.  Insights from the European Respiratory Society 2018 Annual International Congress in the fields of thoracic surgery and lung transplantation.

Authors:  Rogier A S Hoek; Stelios Gaitanakis; Merel E Hellemons
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

5.  Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.

Authors:  David J Hall; Maher Baz; Michael J Daniels; Edward Denmark Staples; Charles T Klodell; Lyle L Moldawer; Thomas M Beaver
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-19

6.  Update in lung transplantation 2013.

Authors:  Jamie L Todd; Jason D Christie; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

7.  Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction.

Authors:  Davide Scozzi; Mohsen Ibrahim; Fuyi Liao; Xue Lin; Hsi-Min Hsiao; Ramsey Hachem; Laneshia K Tague; Alberto Ricci; Hrishikesh S Kulkarni; Howard J Huang; Seiichiro Sugimoto; Alexander S Krupnick; Daniel Kreisel; Andrew E Gelman
Journal:  Am J Transplant       Date:  2019-01-25       Impact factor: 8.086

Review 8.  Cytokine-Ion Channel Interactions in Pulmonary Inflammation.

Authors:  Jürg Hamacher; Yalda Hadizamani; Michèle Borgmann; Markus Mohaupt; Daniela Narcissa Männel; Ueli Moehrlen; Rudolf Lucas; Uz Stammberger
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

9.  Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.

Authors:  David M Sayah; Beñat Mallavia; Fengchun Liu; Guadalupe Ortiz-Muñoz; Axelle Caudrillier; Ariss DerHovanessian; David J Ross; Joseph P Lynch; Rajan Saggar; Abbas Ardehali; Lorraine B Ware; Jason D Christie; John A Belperio; Mark R Looney
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

10.  Lung transplantation for cystic fibrosis.

Authors:  Frederick R Adler; Paul Aurora; David H Barker; Mark L Barr; Laura S Blackwell; Otto H Bosma; Samuel Brown; D R Cox; Judy L Jensen; Geoffrey Kurland; George D Nossent; Alexandra L Quittner; Walter M Robinson; Sandy L Romero; Helen Spencer; Stuart C Sweet; Wim van der Bij; J Vermeulen; Erik A M Verschuuren; Elianne J L E Vrijlandt; William Walsh; Marlyn S Woo; Theodore G Liou
Journal:  Proc Am Thorac Soc       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.